Molecular Mechanism of YuPingFeng in the Treatment of Asthma Based on Network Pharmacology and Molecular Docking Technology. 2022

Li Shen, and Jinmiao Lu, and Guangfei Wang, and Cheng Wang, and Zhiping Li
Department of Pharmacy, The Affiliated Suzhou Science & Technology Town Hospital of Nanjing Medical University, Suzhou, Jiangsu 215153, China.

To explore the molecular targets and mechanism of YuPingFeng (YPF) for the treatment of asthma by using network pharmacology and molecular docking. The potential active ingredients and relevant targets of YPF were obtained from the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform (TCMSP). Asthma-related gene targets were retrieved from GeneCards, OMIM, DrugBank, PharmGKB, and TTD databases. The protein-protein (PPI) network between YPF and asthma common targets was constructed by SRING online database and Cytoscape software. GO and KEGG analyses were performed to explore the complicated molecular biological processes and potential pathways. Finally, a molecular docking approach was carried out to verify the results. We obtained 100 potential targets of the 35 active ingredients in YPF and 1610 asthma-related targets. 60 YPF-asthma common targets were selected to perform PPI analysis. Seven core genes were screened based on two topological calculation methods. GO and KEGG results showed that the main pathways of YPF in treating asthma include TNF signaling pathway and PI3K-Akt signaling pathway. Finally, the molecular docking results indicated that the key ingredients of YPF had a good affinity with the relevant core genes. This study reflects the multicomponent, multitarget, and multipathway characteristics of YPF in treating asthma, providing a theoretical and scientific basis for the intervention of asthma by traditional Chinese medicine YPF.

UI MeSH Term Description Entries
D004365 Drugs, Chinese Herbal Chinese herbal or plant extracts which are used as drugs to treat diseases or promote general well-being. The concept does not include synthesized compounds manufactured in China. Chinese Herbal Drugs,Plant Extracts, Chinese,Chinese Drugs, Plant,Chinese Plant Extracts,Extracts, Chinese Plant,Herbal Drugs, Chinese
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000091484 Network Pharmacology A systems-based pharmacologic discovery process used to predict the multiple targets of multiple drugs in a complex mixture such as CHINESE HERBAL DRUGS. It involves analytical detection of chemicals plus prediction of pharmacologic activity and protein targets for each compound in the mixture and aggregating the net physiological effect. Drug-Target Network,Systematic Pharmacology,Systems Pharmacology,Drug Target Network,Drug-Target Networks,Network, Drug-Target,Networks, Drug-Target,Pharmacology, Network,Pharmacology, Systematic,Pharmacology, Systems
D001249 Asthma A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL). Asthma, Bronchial,Bronchial Asthma,Asthmas
D013672 Technology The application of scientific knowledge to practical purposes in any field. It includes methods, techniques, and instrumentation. Industrial Arts,Arts, Industrial
D062105 Molecular Docking Simulation A computer simulation technique that is used to model the interaction between two molecules. Typically the docking simulation measures the interactions of a small molecule or ligand with a part of a larger molecule such as a protein. Molecular Docking,Molecular Docking Simulations,Molecular Docking Analysis,Analysis, Molecular Docking,Docking Analysis, Molecular,Docking Simulation, Molecular,Docking, Molecular,Molecular Docking Analyses,Molecular Dockings,Simulation, Molecular Docking
D019869 Phosphatidylinositol 3-Kinases Phosphotransferases that catalyzes the conversion of 1-phosphatidylinositol to 1-phosphatidylinositol 3-phosphate. Many members of this enzyme class are involved in RECEPTOR MEDIATED SIGNAL TRANSDUCTION and regulation of vesicular transport with the cell. Phosphatidylinositol 3-Kinases have been classified both according to their substrate specificity and their mode of action within the cell. PI-3 Kinase,Phosphatidylinositol-3-OH Kinase,PtdIns 3-Kinase,PI 3-Kinase,PI-3K,PI3 Kinases,PI3-Kinase,Phosphoinositide 3 Kinases,Phosphoinositide 3-Hydroxykinase,PtdIns 3-Kinases,3-Hydroxykinase, Phosphoinositide,Kinase, PI-3,Kinase, Phosphatidylinositol-3-OH,Kinases, PI3,Kinases, Phosphoinositide 3,PI 3 Kinase,PI3 Kinase,Phosphatidylinositol 3 Kinases,Phosphatidylinositol 3 OH Kinase,Phosphoinositide 3 Hydroxykinase,PtdIns 3 Kinase,PtdIns 3 Kinases

Related Publications

Li Shen, and Jinmiao Lu, and Guangfei Wang, and Cheng Wang, and Zhiping Li
September 2021, BMC complementary medicine and therapies,
Li Shen, and Jinmiao Lu, and Guangfei Wang, and Cheng Wang, and Zhiping Li
January 2020, BioMed research international,
Li Shen, and Jinmiao Lu, and Guangfei Wang, and Cheng Wang, and Zhiping Li
January 2020, Life sciences,
Li Shen, and Jinmiao Lu, and Guangfei Wang, and Cheng Wang, and Zhiping Li
January 2024, Drug design, development and therapy,
Li Shen, and Jinmiao Lu, and Guangfei Wang, and Cheng Wang, and Zhiping Li
January 2022, Applied bionics and biomechanics,
Li Shen, and Jinmiao Lu, and Guangfei Wang, and Cheng Wang, and Zhiping Li
August 2023, Zhonghua nan ke xue = National journal of andrology,
Li Shen, and Jinmiao Lu, and Guangfei Wang, and Cheng Wang, and Zhiping Li
November 2022, Medical science monitor : international medical journal of experimental and clinical research,
Li Shen, and Jinmiao Lu, and Guangfei Wang, and Cheng Wang, and Zhiping Li
January 2022, Evidence-based complementary and alternative medicine : eCAM,
Li Shen, and Jinmiao Lu, and Guangfei Wang, and Cheng Wang, and Zhiping Li
May 2024, Biochemical genetics,
Li Shen, and Jinmiao Lu, and Guangfei Wang, and Cheng Wang, and Zhiping Li
January 2022, Evidence-based complementary and alternative medicine : eCAM,
Copied contents to your clipboard!